Eton Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ETON Eton Pharmaceuticals Inc
VINO Gaucho Group Holdings Inc
LIFW MSP Recovery Inc
ASNS Actelis Networks Inc
AHI Advanced Health Intelligence Ltd
OTLK Outlook Therapeutics Inc
PBHC Pathfinder Bancorp Inc (MARYLAND)
CMA Comerica Inc
IART Integra Lifesciences Holdings Corp
ARKW.SO ARK Next Generation Internet ETF
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Eton Pharmaceuticals, Inc. is a pharmaceutical company, which is developing, acquiring and commercializing products to address unmet needs in patients suffering from rare diseases. It has three commercial rare disease products, ALKINDI SPRINKLE for the treatment of adrenocortical insufficiency, Carglumic Acid for the treatment of hyperammonemia due to N-acetylglutamate synthase deficiency, and Betaine Anhydrous for the treatment of homocystinuria. It also has three additional product candidates in late-stage development. The Company is developing dehydrated alcohol injection, which has received Orphan Drug Designation for the treatment of methanol poisoning, ZENEO hydrocortisone autoinjector for the treatment of adrenal crisis, and ET-400. Its dehydrated alcohol injection product candidate is under review for the treatment of methanol poisoning. Its ZENEO hydrocortisone autoinjector product candidate is a needle-free autoinjector under development for the treatment of adrenal crisis.

Closing Price
$4.04
Day's Change
0.13 (3.32%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.10
Day's Low
3.90
Volume
(Light)
Volume:
93,192

10-day average volume:
185,397
93,192
  • Prev Close
    3.91
  • Today's Open
    3.91
  • Day's Range
    3.90-4.10
  • Avg Vol (10-day)
    185.4K
  • Last (time)
    3:59p ET 10/04/23
  • Last (size)
    1
  • 52-Wk Range
    1.98 - 5.81
    LowHigh
  • (10/21/22 - 09/15/23)
    30.46%
  • 77.6%
  • Market Cap
    103.6M
  • Shares Outstanding
    25.7M
  • -0.01
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • 23.14
  • (% of float 09/15/23)
    4.24

Latest News

October 04, 2023
10:47 am ET
Zacks
6:50 am ET
Globe Newswire
October 03, 2023
11:28 am ET
Zacks
10:50 am ET
Zacks
September 29, 2023
10:18 am ET
Zacks
September 27, 2023
9:52 am ET
Zacks
9:02 am ET
Zacks
September 26, 2023
9:53 am ET
Zacks
September 25, 2023
11:12 am ET
Zacks
September 22, 2023
11:08 am ET
Zacks
11:04 am ET
Zacks
September 21, 2023
11:28 am ET
Zacks
September 20, 2023
8:40 am ET
Zacks
September 18, 2023
10:56 am ET
Zacks
September 13, 2023
10:23 am ET
Zacks
September 12, 2023
7:50 am ET
Zacks
August 30, 2023
10:51 am ET
Zacks
August 23, 2023
6:50 am ET
Globe Newswire
August 21, 2023
12:41 pm ET
Zacks
August 18, 2023
12:40 pm ET
Zacks
August 16, 2023
9:20 am ET
Zacks
8:15 am ET
Zacks
August 14, 2023
9:31 am ET
PR Newswire
August 11, 2023
9:31 am ET
PR Newswire
August 10, 2023
4:40 pm ET
Zacks
4:01 pm ET
Globe Newswire
August 08, 2023
9:50 am ET
Zacks
August 01, 2023
4:05 pm ET
Globe Newswire
July 30, 2023
10:00 am ET
Accesswire
July 29, 2023
3:36 pm ET
Accesswire
July 28, 2023
11:01 am ET
Accesswire
July 27, 2023
11:02 am ET
Accesswire
July 26, 2023
10:14 am ET
Accesswire
July 25, 2023
3:16 pm ET
Accesswire
July 23, 2023
1:46 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.